Research on the Application of Python Technology in Corporate Cost Data Analysis under New Quality Productive Forces
GBP Proceedings Series · 2026
DOI: 10.70088/13ejmv60 ↗Kurz gefasst
Fachartikel in der Zeitschrift GBP Proceedings Series, 2026. Verfasst von Sujin Xu.
Abstract (Originalsprache)
This study investigates how Python-based computational frameworks enhance corporate cost data analysis in the context of emerging new quality productive forces-characterized by digital integration, intelligent decision-making, and high-efficiency resource allocation. Drawing on empirical implementation across diverse industrial sectors, the research identifies core technical pathways through which Python's ecosystem supports granular cost decomposition, dynamic variance detection, and scenario-driven forecasting. It demonstrates that systematic adoption of Python tools enables firms to transition from static, periodic cost reporting to continuous, adaptive cost intelligence. The findings reveal measurable improvements in analytical responsiveness, cross-functional data coherence, and strategic alignment between cost structures and innovation-oriented productivity goals. Importantly, the study clarifies critical organizational prerequisites-including data infrastructure maturity, analyst capability scaffolding, and governance adaptability-that determine the effectiveness of Python deployment beyond mere technical feasibility.
Zitieren
APA
Xu, S. (2026). Research on the Application of Python Technology in Corporate Cost Data Analysis under New Quality Productive Forces. GBP Proceedings Series. https://doi.org/10.70088/13ejmv60
Vancouver
Xu S. Research on the Application of Python Technology in Corporate Cost Data Analysis under New Quality Productive Forces. GBP Proceedings Series. 2026. doi:10.70088/13ejmv60
BibTeX
@article{Xu2026,
author = {Xu, Sujin},
title = {Research on the Application of Python Technology in Corporate Cost Data Analysis under New Quality Productive Forces},
journal = {GBP Proceedings Series},
year = {2026},
doi = {10.70088/13ejmv60}
}
EUVIMED